Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Dictamen del Comité Económico y Social Europeo sobre la «Propuesta de Reglamento del Parlamento Europeo y del Consejo por el que se crea un Centro europeo para la prevención y el control de las enfermedades» (COM (2003) 441 final-2003/0174 (COD) (2004/C 32/11). Disponible en: http://europa.eu.int/eur-lex/pri/es/oj/dat/2004/c_032/c_03220040205es00570060.pdf
[2.]
Reglamento (CE) N.° 851/2004 del Parlamento Europeo y del Consejo de 21 de abril de 2004, por el que se crea un Centro Europeo para la prevención y el control de las Enfermedades. Diario Oficial n.° L 142 de 30/04/2004 p. 0001-0011. Disponible en: http://europa.eu.int/eur-lex/lex/LexUriServ/LexUriServ.do?uri=CELEX:32004R0851:ES:HTML
[3.]
Minutes of the sixth meeting of the ECDC Management Board, Stockholm, 20-21 March 2006. Disponible en: http://www.ecdc.eu.int/About_us/governance/MB/Minutes/Minutes_MB6.pdf
[4.]
Alonso PL. Trends in international health: challenges and opportunities for our society. Gac Sanit [on line]. 2003;17:175-8. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttextπd=S0213-91112003000300001&lng=en&nrm=iso>. ISSN0213-9111
[5.]
Fernández de la Hoz K, Arias P. La vigencia de la salud pública. El País (30/10/2001). Disponible en: http://www.elpais.es/articulo/salud/vigencia/salud/publica/elpepisoc/20011030elpepisal_8/Tes/
[6.]
K. Fernández de la Hoz, R. Kaiser, M. Ciotti.
La Unión Europea ante las crisis sanitarias.
RAS, 4 (2006), pp. 425-435
[7.]
European Centre is an important part of longer term response to SARS and similar threats. Eurosurveillance Weekly [1812-075X]. 2003;5:030501. Disponible en: http://www.eurosurveillance.org/ew/2003/030501.asp#3
[8.]
J.H. Beigel, J. Farrar, A.M. Han, F.G. Hayden, R. Hyer, M.D. De Jong, et al.
Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans.
N Engl J Med, 353 (2005), pp. 1374-1385
[9.]
P. Godoy.
Pandemia de gripe aviar: un nuevo desafío para la salud pública [editorial].
Gac Sanit, 20 (2006), pp. 4-8
[10.]
ECDC. Annual Epidemiological Report on Communicable Diseases in Europe. Report on the status of communicable diseases in the EU and EEA/EFTA countries. Disponible en: http://www.ecdc.europa.eu/pdf/Epi_report_2007.pdf
[11.]
EuroTB and the national coordinators for tuberculosis in the WHO European Region Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2005. Institut de Veille Sanitaire. Saint-Maurice, France, March 2007. Disponible en: http://www.eurotb.org/rapports/2005/full_report.pdf
[12.]
Commission Decision 2000/96/EC on the communicable diseases to be progressively covered by the Community network under Decision N.° 2119/98/EC of the European Parliament and of the Council. OJ L28, 3.2.2000. p. 50. Disponible en: http://europa.eu.int/eur-lex/pri/en/oj/dat/2000/l_028/l_02820000203en00500053.pdf
[13.]
Commission Decision No. 2119/98/EC of the European Parliament and of the Council setting up a network fort the epidemiological surveillance and control of communicable diseases in the Community. OJ L268, 3.10.1998. p. 1. Disponible en: http://europa.eu.int/eur-lex/pri/en/oj/dat/1998/l_268/l_26819981003en00010006.pdf
[14.]
Commission Decision 2000/57/EC on the early warning and response system for the prevention and control of communicable diseases under decision 2119/98/EC from the European Parliament and the Council. Disponible en: http://europa.eu.int/eur-lex/pri/en/oj/dat/2000/l_021/l_02120000126en003 20035.pdf
[15.]
Commission Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision N.° 2119/98/EC of the European Parliament and of the Council. OJ L 86, 3.4.2002. p. 44. Disponible en: http://europa.eu.int/eur-lex/pri/en/oj/dat/2002/l_086/l_08620020403en00440062.pdf
[16.]
EuroTB and RIVM. MDR-TB cluster report n.° 6. InVS, Saint-Maurice, France, March 2007. Disponible en: http://www.eurotb.org/mdr_tb_surveillance/pdf/MDR-TB_report6.pdf
[17.]
European Influenza Surveillance Scheme (EISS). Disponible en: http://www.eiss.org/index.cgi
[18.]
Muñoz I, Vanaclocha H, Gónzalez F. La importancia de las redes microbiológicas en el control de las resistencias bacterianas. Rev Esp Quimioter. 2007;20:193-202. Disponible en: http://www.seq.es/seq/0214-3429/20/2/munoz_i_revision1.pdf
[19.]
European Antimicrobial resistance surveillance system (EARSS). Disponible en: http://www.rivm.nl/earss/about/
[20.]
Scientific Evaluation on the Use of Antimicrobial Agents in Human Therapy (ESAC). Disponible en: http://www.esac.ua.ac.be/main.aspx?c=*ESAC2&n=21600
[21.]
Lagadec P. Crisis management in the 21st century «unthinkable» events in «unconceivable» context. Ecole Polytechnique. Centre Nationale de la Recherche Scientifique, February 2005. Disponible en: http://ceco.polytechnique.fr/fichiers/ceco/publications/pdf/2005-03-14-219.pdf
[22.]
Paquet C. Coulombier D.Kaiser R.Ciotti M. Epidemic intelligence: a new framework for strengthening disease surveillance in Europe. Eurosurveillance, 2006 11:212-214. Disponible en: http://www.eurosurveillance.org/em/v11n12/1112-223.asp
[23.]
Interim ECDC risk assessment, October 19th 2005 (updated January 5th 2006). The Public Health risk from Highly Pathogenic Avian Influenza Viruses Emerging in Europe with Specific Reference to type A/H5N1. Disponible en: http://www.ecdc.eu.int/avian_influenza/H5N1_European_Risk_Assessment_ECDC_051019.pdf
[24.]
Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. www.thelancet.com. Published online April 20, 2006 DOI:101016/S0140-6736(06)68511-5
[25.]
Comisión Europea. Education and training. Disponible en: http://ec.europa.eu/education/policies/lang/languages/index_es.html
[26.]
A. Maalouf.
Identidades asesinas.
Alianza Editorial, (1999),
[27.]
Manissero D, Fernández de la Hoz K. Surveillance methods and case definition for extensively drug resistant TB (XDRTB) and relevance to Europe: summary update. Euro Surveill 2006;11(11):E061103.1. Disponible en: http://www.eurosurveillance.org/ew/2006/061103.asp#1
[28.]
Schwoebel V, Lambregts-van Weezenbeek CSB, Moro ML, et al. Standardisation of anti-tuberculosis drug resistance surveillance in Europe: recommendations of a WHO and IUATLD Working Group. Eur Respir J. 2000;16:364-71. Disponible en: http://www.erj.ersjournals.com/cgi/reprint/16/2/364
[29.]
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis. Global trends and interactions with the HIV epidemics. Arch Intern Med. 2003;163:1009-21. EuroHIV. HIV/AIDS Surveillance in Europe. End-year report 2005. Saint-Maurice: Institut de Veille Sanitaire, 2006. N.° 73. Disponible en: http://www.eurohiv.org/reports/report_73/pdf/report_eurohiv_73.pdf
[30.]
Van Loock F, Rowland M, Grein T, Moren A. Intervention epidemiology training: a European perspective. Euro Surveill. 2001;6:37-43. Disponible en: http://www.eurosurveillance.org/em/v06n03/0603-224.asp
[31.]
S. Zweig.
El mundo de ayer: memorias de un europeo.
Editorial Acantilado, (2002),
Copyright © 2007. Sociedad Española de Salud Pública y Administración Sanitaria
